HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

KC 764

structure given in first source; reduces myocardial infarct size, MPO activity, and the activity of arachidonic acid, thromboxane B2 synthesis, plasma glutamate oxalo-acetate transaminase, lactate dehydrogenase, and creatine kinase
Also Known As:
2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo(1,5-a)pyridine; KC-764
Networked: 5 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Related Diseases

1. Ischemia
2. Ischemic Stroke
3. Thrombosis (Thrombus)
4. Myocardial Infarction
5. Infarction (Infarctions)

Related Drugs and Biologics

1. Cyclooxygenase Inhibitors
2. Platelet Aggregation Inhibitors (Antiplatelet Drugs)
3. Glutamic Acid (Glutamate)
4. Prostaglandins
5. Peroxidase (Myeloperoxidase)
6. L-Lactate Dehydrogenase (Lactate Dehydrogenase)
7. Creatine Kinase (Creatine Phosphokinase)
8. Collagen
9. Aspirin (Acetylsalicylic Acid)
10. Transaminases (Aminotransferases)